|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Translational Physiology
1 Molecular Cardiology Laboratory, Greenberg Cardiology Division, Department of Medicine, Weill Medical College of Cornell University, New York, New York 10021
2 Department of Cell and Developmental Biology, Weill Medical College of Cornell University, New York, New York 10021
3 BioReference Laboratories, Elmwod Park, New Jersey 07407
Transcriptional regulatory cascades during epicardial and coronary vascular development from proepicardial progenitor cells remain to be defined. We have used immunohistochemistry of human embryonic tissues to demonstrate that the TBX5 transcription factor is expressed not only in the myocardium, but also throughout the embryonic epicardium and coronary vasculature. TBX5 is not expressed in other human fetal vascular beds. Furthermore, immunohistochemical analyses of human embryonic tissues reveals that unlike their epicardial counterparts, delaminating epicardial-derived cells do not express TBX5 as they migrate through the subepicardium before undergoing epithelial-mesenchymal transformation required for coronary vasculogenesis. In the chick, Tbx5 is expressed in the embryonic proepicardial organ (PEO), which is composed of the epicardial and coronary vascular progenitor cells. Retrovirus-mediated overexpression of human TBX5 inhibits cell incorporation of infected proepicardial cells into the nascent chick epicardium and coronary vasculature. TBX5 overexpression as well as antisense-mediated knockdown of chick Tbx5 produce a cell-autonomous defect in the PEO that prevents proepicardial cell migration. Thus, both increasing and decreasing Tbx5 dosage impairs development of the proepicardium. Culture of explanted PEOs demonstrates that untreated chick proepicardial cells downregulate Tbx5 expression during cell migration. Therefore, we propose that Tbx5 participates in regulation of proepicardial cell migration, a critical event in the establishment of the epicardium and coronary vasculature.
vasculature; epicardium; cardiac development
This article has been cited by other articles:
![]() |
D. A. McDermott, C. J. Hatcher, and C. T. Basson Atrial Fibrillation and Other Clinical Manifestations of Altered TBX5 Dosage in Typical Holt-Oram Syndrome Circ. Res., September 26, 2008; 103(7): e96 - e96. [Full Text] [PDF] |
||||
![]() |
Y. Ishii, J. D. Langberg, R. Hurtado, S. Lee, and T. Mikawa Induction of proepicardial marker gene expression by the liver bud Development, October 15, 2007; 134(20): 3627 - 3637. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-R. Song, R. Shirasaki, C.-L. Cai, E. C. Ruiz, S. M. Evans, S.-K. Lee, and S. L. Pfaff T-Box transcription factor Tbx20 regulates a genetic program for cranial motor neuron cell body migration. Development, December 1, 2006; 133(24): 4945 - 4955. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Camarata, B. Bimber, A. Kulisz, T.-L. Chew, J. Yeung, and H.-G. Simon LMP4 regulates Tbx5 protein subcellular localization and activity J. Cell Biol., July 31, 2006; 174(3): 339 - 348. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. H. Fong, A. Emelyanov, C. Teh, and V. Korzh Wnt signalling mediated by Tbx2b regulates cell migration during formation of the neural plate Development, August 15, 2005; 132(16): 3587 - 3596. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |